(Q79215056)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030495%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030495%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

1 reference

1 reference

1 reference

5

Jussi Mertsola

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030495%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

6

Qiushui He

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030495%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Annika Elomaa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030495%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Abdolreza Advani

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030495%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Declan Donnelly

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030495%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Mia Antila

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030495%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Hans Hallander

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030495%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

20 September 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030495%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030495%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030495%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030495%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

918-926

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030495%20AND%20SRC:MED&resulttype=core&format=json

Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935-1999

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Changes in the Dutch Bordetella pertussis population in the first 20 years after the introduction of whole-cell vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Polymorphism of Bordetella pertussis isolates circulating for the last 10 years in France, where a single effective whole-cell vaccine has been used for more than 30 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Temporal trends in circulating Bordetella pertussis strains in Australia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Bordetella pertussisProtein Pertactin Induces Type‐Specific Antibodies: One Possible Explanation for the Emergence of Antigenic Variants?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Development of acellular pertussis vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Pertussis in Sweden after the cessation of general immunization in 1979.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Declining pertussis incidence in Sweden following the introduction of acellular pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Rapid identification of Bordetella pertussis pertactin gene variants using LightCycler real-time polymerase chain reaction combined with melting curve analysis and gel electrophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Rapid typing of Bordetella pertussis pertussis toxin gene variants by LightCycler real-time PCR and fluorescence resonance energy transfer hybridization probe melting curve analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Masseteric silent period in healthy young adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Antigenic divergence suggested by correlation between antigenic variation and pulsed-field gel electrophoresis profiles of Bordetella pertussis isolates in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

The seroepidemiology of Bordetella pertussis infection in Western Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Impact of immunisation on pertussis transmission in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Effect of the preschool pertussis booster on national notifications of disease in Australia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Potency of pertussis component in the DTP vaccine--an overview of three decade study in Poland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Pertussis vaccination beyond childhood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Clinical practice. Pertussis--not just for kids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Pertussis of adults and infants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Emerging infectious diseases: vulnerabilities, contributing factors and approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

Molecular epidemiology of Bordetella pertussis by pulsed-field gel electrophoresis profile: Cincinnati, 1989-1996

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.09.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2006.09.012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17030495%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference